194 related articles for article (PubMed ID: 25453942)
1. Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators.
Vasconcelos DP; Costa M; Amaral IF; Barbosa MA; Águas AP; Barbosa JN
Biomaterials; 2015 Jan; 37():116-23. PubMed ID: 25453942
[TBL] [Abstract][Full Text] [Related]
2. Development of an immunomodulatory biomaterial: using resolvin D1 to modulate inflammation.
Vasconcelos DP; Costa M; Amaral IF; Barbosa MA; Águas AP; Barbosa JN
Biomaterials; 2015; 53():566-73. PubMed ID: 25890752
[TBL] [Abstract][Full Text] [Related]
3. Macrophage polarization following chitosan implantation.
Vasconcelos DP; Fonseca AC; Costa M; Amaral IF; Barbosa MA; Águas AP; Barbosa JN
Biomaterials; 2013 Dec; 34(38):9952-9. PubMed ID: 24074837
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
Kang JW; Lee SM
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
[TBL] [Abstract][Full Text] [Related]
6. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A
Simões RL; De-Brito NM; Cunha-Costa H; Morandi V; Fierro IM; Roitt IM; Barja-Fidalgo C
Int J Cancer; 2017 Jan; 140(2):346-357. PubMed ID: 27615282
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.
Sok MCP; Tria MC; Olingy CE; San Emeterio CL; Botchwey EA
Acta Biomater; 2017 Apr; 53():109-122. PubMed ID: 28213094
[TBL] [Abstract][Full Text] [Related]
9. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release.
Abdelmoaty S; Wigerblad G; Bas DB; Codeluppi S; Fernandez-Zafra T; El-Awady el-S; Moustafa Y; Abdelhamid Ael-D; Brodin E; Svensson CI
PLoS One; 2013; 8(9):e75543. PubMed ID: 24086560
[TBL] [Abstract][Full Text] [Related]
10. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.
Lee HN; Surh YJ
Biochem Pharmacol; 2013 Sep; 86(6):759-69. PubMed ID: 23856291
[TBL] [Abstract][Full Text] [Related]
11. Chitosan porous 3D scaffolds embedded with resolvin D1 to improve in vivo bone healing.
Vasconcelos DP; Costa M; Neves N; Teixeira JH; Vasconcelos DM; Santos SG; Águas AP; Barbosa MA; Barbosa JN
J Biomed Mater Res A; 2018 Jun; 106(6):1626-1633. PubMed ID: 29453815
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues.
Lastrucci C; Baillif V; Behar A; Al Saati T; Dubourdeau M; Maridonneau-Parini I; Cougoule C
FASEB J; 2015 May; 29(5):1914-29. PubMed ID: 25609430
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
Jin Y; Arita M; Zhang Q; Saban DR; Chauhan SK; Chiang N; Serhan CN; Dana R
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4743-52. PubMed ID: 19407006
[TBL] [Abstract][Full Text] [Related]
15. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds.
Spiller KL; Nassiri S; Witherel CE; Anfang RR; Ng J; Nakazawa KR; Yu T; Vunjak-Novakovic G
Biomaterials; 2015 Jan; 37():194-207. PubMed ID: 25453950
[TBL] [Abstract][Full Text] [Related]
16. The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.
Li G; Wu P; Xu Y; Yu Y; Sun L; Zhu L; Ye D
BMC Musculoskelet Disord; 2009 Jun; 10():57. PubMed ID: 19490628
[TBL] [Abstract][Full Text] [Related]
17. Artificial extracellular matrices composed of collagen I and high-sulfated hyaluronan promote phenotypic and functional modulation of human pro-inflammatory M1 macrophages.
Franz S; Allenstein F; Kajahn J; Forstreuter I; Hintze V; Möller S; Simon JC
Acta Biomater; 2013 Mar; 9(3):5621-9. PubMed ID: 23168224
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration.
Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S
Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251
[TBL] [Abstract][Full Text] [Related]
19. Activation of autophagy in macrophages by pro-resolving lipid mediators.
Prieto P; Rosales-Mendoza CE; Terrón V; Toledano V; Cuadrado A; López-Collazo E; Bannenberg G; Martín-Sanz P; Fernández-Velasco M; Boscá L
Autophagy; 2015; 11(10):1729-44. PubMed ID: 26506892
[TBL] [Abstract][Full Text] [Related]
20. Lipoxin A4 regulates M1/M2 macrophage polarization via FPR2-IRF pathway.
Yuan J; Lin F; Chen L; Chen W; Pan X; Bai Y; Cai Y; Lu H
Inflammopharmacology; 2022 Apr; 30(2):487-498. PubMed ID: 35235107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
